Using a combination of lectures, guest speakers, discussion, and case studies, students will explore how fundamental advances in immunology are being developed as next generation reagents, biomarkers, therapeutics, vaccines, and therapeutic immune cells. The course will be composed of 12 two-hour sessions. Each of the first 10 sessions will be composed of a lecture component followed by related discussion of the topic. For some sessions, experts in industry will be brought in as guest lecturers and discussants. Students will present their case studies in the final two sessions.